Inhibition of HIV-1 group M and O isolates by fusion inhibitors

被引:19
作者
Chinnadurai, R
Münch, A
Dittmar, MT
Kirchhoff, F
机构
[1] Univ Ulm, Dept Virol, D-89081 Ulm, Germany
[2] Hyg Inst, Dept Virol, D-69120 Heidelberg, Germany
关键词
D O I
10.1097/01.aids.0000188425.79914.e4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We examined the susceptibility of HIV-1 group M and 0 isolates to the fusion inhibitors T-20 and T-1249. Unexpectedly, HIV-1 0 isolates were as sensitive as group M viruses to inhibition by T-20 but were usually less susceptible to T-1249. Our data suggest that T-20 has broad antiretroviral activity and would be effective in individuals with HIV-1 0 infection. However, polymorphisms in gp41 might affect the sensitivity of HIV-1 0 to second-generation fusion inhibitors.
引用
收藏
页码:1919 / 1922
页数:4
相关论文
共 22 条
  • [1] Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target
    Chan, DC
    Chutkowski, CT
    Kim, PS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) : 15613 - 15617
  • [2] Effect of naturally-occurring gp41 HR1 variations on susceptibility of HIV-1 to fusion inhibitors
    Chinnadurai, R
    Münch, J
    Kirchhoff, F
    [J]. AIDS, 2005, 19 (13) : 1401 - 1405
  • [3] Coreceptor requirements of primary HIV type 1 group O isolates from Cameroon
    Dittmar, MT
    Zekeng, L
    Kaptue, L
    Eberle, J
    Kräusslich, HG
    Gürtler, L
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (08) : 707 - 712
  • [4] Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV
    Eron, JJ
    Gulick, RM
    Bartlett, JA
    Merigan, T
    Arduino, R
    Kilby, JM
    Yangco, B
    Diers, A
    Drobnes, C
    DeMasi, R
    Greenberg, M
    Melby, T
    Raskino, C
    Rusnak, P
    Zhang, Y
    Spence, R
    Miralles, GD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (06) : 1075 - 1083
  • [5] GENETIC-VARIATION OF HIV TYPE-1 IN 4 WORLD-HEALTH-ORGANIZATION-SPONSORED VACCINE EVALUATION SITES - GENERATION OF FUNCTIONAL ENVELOPE (GLYCOPROTEIN-160) CLONES REPRESENTATIVE OF SEQUENCE SUBTYPE-A, SUBTYPE-B, SUBTYPE-C, AND SUBTYPE-E
    GAO, F
    YUE, L
    CRAIG, S
    THORNTON, CL
    ROBERTSON, DL
    MCCUTCHAN, FE
    BRADAC, JA
    SHARP, PM
    HAHN, BH
    OSMANOV, S
    BELSEY, EM
    HEYWARD, W
    ESPARZA, J
    GALVAOCASTRO, B
    VANDEPERRE, P
    KARITA, E
    WASI, C
    SEMPALA, S
    TUGUME, B
    BIRYAHWAHO, B
    RUBSAMENWAIGMANN, H
    VONBRIESEN, H
    ESSER, R
    GREZ, M
    HOLMES, H
    NEWBERRY, A
    RANJBAR, S
    TOMLINSON, P
    BRADAC, J
    MCCUTCHAN, F
    LOUWAGIE, J
    HEGERICH, P
    LOPEZGALINDEZ, C
    OLIVARES, I
    DOPAZO, J
    MULLINS, JI
    DELWART, EL
    BACHMANN, HM
    GOUDSMIT, J
    DEWOLF, F
    SARAGOSTI, S
    SCHOCHETMAN, G
    KALISH, M
    LUO, CC
    GEORGE, R
    PAU, CP
    WEBER, J
    CHEINGSONGPOPOV, R
    KALEEBU, P
    NARA, P
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (11) : 1359 - 1368
  • [6] Greenberg ML, 2002, ANTIVIR THER, V7, pS14
  • [7] Determinants of human immunodeficiency virus type 1 baseline susceptibility to the fusion inhibitors enfuvirtide and T-649 reside outside the peptide interaction site
    Heil, ML
    Decker, JM
    Sfakianos, JN
    Shaw, GM
    Hunter, E
    Derdeyn, CA
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (14) : 7582 - 7589
  • [8] Kandathil AJ, 2005, INDIAN J MED RES, V121, P333
  • [9] T-1249 retains potent antiretroviral activity in patients who had experienced virological failure while on an enfuvirtide-containing treatment regimen
    Lalezari, JP
    Bellos, NC
    Sathasivam, K
    Richmond, GJ
    Cohen, CJ
    Myers, RA
    Henry, DH
    Raskino, C
    Melby, T
    Murchison, H
    Zhang, Y
    Spence, R
    Greenberg, ML
    DeMasi, RA
    Miralles, GD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (07) : 1155 - 1163
  • [10] Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America
    Lalezari, JP
    Henry, K
    O'Hearn, M
    Montaner, JSG
    Piliero, PJ
    Trottier, B
    Walmsley, S
    Cohen, C
    Kuritzkes, DR
    Eron, JJ
    Chung, J
    DeMasi, R
    Donatacci, L
    Drobnes, C
    Delehanty, J
    Salgo, M
    Farthing, C
    Graham, E
    Packard, M
    Ngo, L
    Lederman, M
    Buam, J
    Pollard, R
    Rauf, S
    Silkowski, W
    Thompson, M
    Rucker, A
    Harris, M
    Larsen, G
    Preseon, S
    Cunningham, D
    Guimaraes, D
    Bertasso, A
    Kinchelow, T
    Myers, R
    Phoenix, BCBP
    Skolnik, PR
    Adams, B
    Leite, OHM
    Oliveira, M
    Lefebvre, E
    Gomez, B
    Foy, KB
    Lampiris, H
    Charles, S
    Dobkin, J
    Crawford, M
    Slom, T
    Murphy, R
    Mikaitis, T
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (22) : 2175 - 2185